Sorrento Therapeutics, Inc.
Antigen binding proteins that bind PD-L1

Last updated:

Abstract:

There is disclosed anti-PD-L1 IgG class antibodies that have an improved ability to be manufactured at higher yields. More specifically, there is disclosed human antibodies that bind PD-L1, PD-L1-binding fragments that can be manufactured at higher yields.

Status:
Grant
Type:

Utility

Filling date:

10 Oct 2018

Issue date:

16 Feb 2021